Elizabeth Raetz
Vice Chair, Clinical Affairs · NYU Grossman School of Medicine
Credentials: · · ·
History
Research
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
New England Journal of Medicine · 2014 · 1,124 citations
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Nature Genetics · 2017 · 759 citations
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Nature Genetics · 2019 · 494 citations
138 papers
135 papers
134 papers
89 papers
65 papers
- MB
60 papers
50 papers
Mary Relling
39 papers
Grants
- 1998–2003
pp2a Regulation Subunits in Cellular Growth
National Institute of Child Health and Human Development · K08
Contact PI · $431.5K · Utah State Higher Education System--University of Utah
Clinical trials
- 2005–2011
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
Principal investigator · Completed · Phase 1, Phase 2
Children's Oncology Group
- 2003
Principal investigator · Completed
National Cancer Institute (NCI)
- 2019–2023
Study chair · Completed · Phase 1
Children's Oncology Group
- 2010–2012
Study chair · Terminated · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium